Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis
about
Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studiesThe risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents.Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplastyNon-steroidal anti-inflammatory drugs for low back painNon-steroidal anti-inflammatory drugs for low-back painRofecoxib for osteoarthritisNon-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplastyCyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysisGastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humansTime dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approachCyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapyRisk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulationsCOX-2: where are we in 2003?--distinction from NSAIDs becoming blurredTOIB Study. Are topical or oral ibuprofen equally effective for the treatment of chronic knee pain presenting in primary care: a randomised controlled trial with patient preference study. [ISRCTN79353052].Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDsPiroxicam-β-cyclodextrin: a GI safer piroxicamGuidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapyEffects of buffered and plain acetylsalicylic acid formulations with and without ascorbic acid on gastric mucosa in healthy subjectsNSAIDs: gastroprotection or selective COX-2 inhibitor?Effect of nonsteroidal anti-inflammatory drug use on the rate of gastrointestinal hospitalizations among people living in long-term careUlcer complications associated with anti-inflammatory drug use. What is the extent of the disease burden?Endoscopic evaluation of the gastrotolerance of short-term antalgic treatment with low dose k-diclofenac: a comparison of ibuprofen and aspirinAssociation between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studiesBalancing the gastrointestinal benefits and risks of nonselective NSAIDs.Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in DenmarkContraindicated NSAIDs are frequently prescribed to elderly patients with peptic ulcer diseaseInteractions between Helicobacter pylori and other risk factors for peptic ulcer bleedingCyclooxygenase inhibition: between the devil and the deep blue seaGastrointestinal tolerability of ibuprofen compared with paracetamol and aspirin at over-the-counter dosesHospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medicationsFatty acid ethyl ester, a non-oxidative ethanol metabolite, reverses the inhibitory effect of ibuprofen on platelet aggregationAdverse effects of conventional non-steroidal anti-inflammatory drugs on the upper gastrointestinal tractPrimer: managing NSAID-induced ulcer complications--balancing gastrointestinal and cardiovascular risksCurrent approaches to prevent NSAID-induced gastropathy--COX selectivity and beyondThe rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritisShould we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?The application of prescribing indicators to a primary care prescription database in IrelandRisk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinationsA large simple clinical trial prototype for assessment of OTC drug effects using patient-reported data
P2860
Q21144617-899ACEF0-46CA-4A34-AD64-539B660B5D0CQ21195670-70399D20-A34A-446C-8360-805EE199B6B3Q24200252-9ED0A52D-9F06-48F3-ACFE-4571885ED2E6Q24242320-24FDAD14-6D20-43CD-896F-2D9B00D824A0Q24243968-B52AB03E-A6D8-4BE9-A6F7-34212C9E7116Q24244871-FA5D157A-8EF7-4796-91F3-C50FAE764431Q24246587-947ED8AD-9C40-401C-A419-34EFB521AFD3Q24536027-4AD0B036-A658-44A3-B684-41369D661D54Q24646764-8708F22F-7499-4783-BA4C-ECEB2BC67EACQ24669542-8752FD47-8577-4A84-B3CC-EAC6E759E694Q24673561-A887CA25-7E2D-47D5-A39E-4BE9D827F9DAQ24675327-95ACDCD7-A663-40A7-9552-C3A1B29CDBACQ24798492-754DCF2E-2CA1-4A2B-B378-3F99E999D1CBQ24804373-25D9E5A1-3E81-4161-B4E2-D27A643187C6Q24811516-24CA04F9-36D9-4F3E-9C6F-DC013A3274E0Q26800279-985FAD43-851F-4E1F-83A0-21ADFA3AC8C9Q27023475-AE318777-13BA-462E-966E-16EB3AF63E87Q28166768-52C8033E-F22A-43C9-B8E9-1DAE32BABD20Q28167440-D07EC52F-C7D0-410B-862F-870A4CCDB246Q28168965-5253E856-D288-4C81-A89A-F10FFDC1F179Q28184371-0E133BE5-BAD1-433F-BF7F-878B1115E31BQ28185419-3B60CA8C-8D02-46D0-B26F-2099DFCAA952Q28186738-E75A0994-8BA3-4BB8-9B4F-CE1F23B4347CQ28191843-AD2781ED-10BD-46EE-AAE4-933BC134FA33Q28191932-6C81A391-4E93-4056-8837-72C97DE8BD5BQ28192383-2193B710-1071-4FB7-B52F-ADDACECF06CFQ28192384-4CCBC454-00D2-455F-B3A9-6B7A45FAC37EQ28192471-209896B0-75A3-478A-BC40-1244E3A5A406Q28192790-00325388-A241-458F-8963-A108B42D1AE8Q28193558-44837521-CAD5-4200-86B9-7C203F3E1332Q28193963-99F294A1-4F9A-4555-A050-F51F0F3E4C5FQ28194474-C2CBDFBA-031A-425A-A6F4-12FAE0C1BDC5Q28199102-0993A58E-4F6F-49AD-8CC4-F52FA96D8A20Q28200571-557C452F-CF59-4277-8A0C-2965F4E6B88AQ28210656-2ECAD86B-D8AD-41A1-85A5-1F8E5F3A9680Q28211833-56F3098B-9809-44D4-A636-B16CEFC2D31FQ28213638-7A10278F-A481-4B76-8F57-5FB02481589FQ28217800-8F3237DC-2FCE-4C63-A51E-EC88BF6F2426Q28217824-90099373-05AE-4070-957F-8A811B21511DQ28218001-D460B975-64FA-4DDA-8405-1CD07381DBCA
P2860
Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Variability in risk of gastroi ...... a collaborative meta-analysis
@ast
Variability in risk of gastroi ...... a collaborative meta-analysis
@en
Variability in risk of gastroi ...... a collaborative meta-analysis
@nl
type
label
Variability in risk of gastroi ...... a collaborative meta-analysis
@ast
Variability in risk of gastroi ...... a collaborative meta-analysis
@en
Variability in risk of gastroi ...... a collaborative meta-analysis
@nl
prefLabel
Variability in risk of gastroi ...... a collaborative meta-analysis
@ast
Variability in risk of gastroi ...... a collaborative meta-analysis
@en
Variability in risk of gastroi ...... a collaborative meta-analysis
@nl
P2093
P2860
P921
P3181
P1433
P1476
Variability in risk of gastroi ...... a collaborative meta-analysis
@en
P2093
J L Carson
L A Garcia Rodriguez
P2860
P304
P3181
P356
10.1136/BMJ.312.7046.1563
P407
P577
1996-06-22T00:00:00Z